USANA Health Sciences to List Shares on the New York Stock Exchange
SALT LAKE CITY, Dec 21, 2010 (BUSINESS WIRE) --
USANA Health Sciences, Inc. (NASDAQ: USNA) today announced that it has completed the application process and has been authorized to transfer the listing of its common stock to the New York Stock Exchange ("NYSE"). USANA expects its shares to begin trading on the NYSE on January 3, 2011, using its symbol "USNA". Until that time, USANA's common stock will continue to trade on the NASDAQ Global Select Market.
"We are pleased to list USANA on the NYSE, which is widely recognized as the world's premier stock exchange," said Dave Wentz, CEO of USANA Health Sciences. "This move represents an important partnership for USANA as we continue to increase our global brand presence for our Associates, Customers, and shareholders worldwide."
"USANA Health Sciences is an innovator that focuses on improving the lives and well-being of people throughout the world," said Scott Cutler, Head of Listings, Americas and Executive Vice President, NYSE Euronext. "We welcome USANA to the New York Stock Exchange and look forward to providing the highest levels of market quality and service to the company and its shareholders."
USANA develops and manufactures high quality nutritional, personal care, and weight management products that are sold directly to Associates and Preferred Customers throughout the United States, Canada, Australia, New Zealand, Hong Kong, Japan, Taiwan, South Korea, Singapore, Mexico, Malaysia, the Philippines, the Netherlands, and the United Kingdom. Additionally, USANA's wholly owned subsidiary, BabyCare, Ltd., operates a direct selling business in China. More information on USANA can be found at http://www.usanahealthsciences.com
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act. Our actual results could differ materially from those projected in these forward-looking statements, which involve a number of risks and uncertainties, including global economic conditions generally, reliance upon our network of independent Associates, the governmental regulation of our products, manufacturing and marketing risks, adverse publicity risks, and risks associated with our international expansion. The contents of this release should be considered in conjunction with the risk factors, warnings, and cautionary statements that are contained in our most recent filings with the Securities and Exchange Commission.
SOURCE: USANA Health Sciences, Inc.
USANA Health Sciences, Inc.
Investors contact: Patrique Richards, 801-954-7961
Investor Relations email@example.com
Media contact: Dan Macuga, 801-954-7280